Angiotensin-converting enzyme inhibitor-related angioedema: recognition and treatment.
Flattery
Maureen P
MP
Pauley Heart Center, Virginia Commonwealth University Health System, Richmond, VA 23298, USA. mflatter@hsc.vcu.edu
Sica
Domenic A
DA
D000799:Angioedema / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects; D001920:Bradykinin / Q000187:drug effects / Q000502:physiology; D018819:Dipeptidyl Peptidase 4 / Q000187:drug effects / Q000502:physiology; D016903:Drug Monitoring; D006801:Humans; D015994:Incidence; D001121:Lysine Carboxypeptidase / Q000187:drug effects / Q000502:physiology; D018579:Patient Selection; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D018819:Dipeptidyl Peptidase 4; D001121:Lysine Carboxypeptidase; D001920:Bradykinin